ConductScience.org, home

Paper25535693

Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.

Morgensztern D and 23 others. J Thorac Oncol, 2015. Cited by 112 papers, by iCite.

Cite this record

ConductScience Library. Molecularly targeted therapies in non-small-cell lung cancer annual update 2014. Papers, record 25535693. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25535693

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.
PubMed
Journal
J Thorac Oncol
PubMed
Year
2015
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
112
iCite
Relative citation ratio, by iCite
3.1
iCite
Revised in PubMed
2024-10-03
PubMed

Authors24

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Morgensztern DDaniel
2Campo MJMeghan J
3Dahlberg SESuzanne E
4Doebele RCRobert C
5Garon EEdward
6Gerber DEDavid E
7Goldberg SBSarah B
8Hammerman PSPeter S
9Heist RSRebecca S
10Hensing TThomas
11Horn LLeora
12Ramalingam SSSuresh S
13Rudin CMCharles M
14Salgia RRavi
15Sequist LVLecia V
16Shaw ATAlice T
17Simon GRGeorge R
18Somaiah NNeeta
19Spigel DRDavid R
20Wrangle JJohn

Source PubMed

See all 24 authorsDownload CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Non-Small-Cell LungMajor topic
Lung NeoplasmsMajor topic
Genetic Therapy
Humans
Immunotherapy
Molecular Targeted Therapy
Randomized Controlled Trials as Topic

Source PubMed

Download CSV of topics

Grants8

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA006973NCI NIH HHSUnited StatesP30CA006973PubMed and NIHNIH RePORTER
T32 CA009071NCI NIH HHSUnited StatesT32CA009071PubMed and NIHNIH RePORTER
K12 CA167540NCI NIH HHSUnited StatesK12CA167540PubMed and NIHNIH RePORTER
R21 CA170063NCI NIH HHSUnited StatesR21CA170063PubMed and NIHNIH RePORTER
R01 CA182746NCI NIH HHSUnited StatesR01CA182746PubMed and NIHNIH RePORTER
UL1 TR000142NCATS NIH HHSUnited StatesUL1TR000142PubMed and NIHNIH RePORTER
K23 CA149079NCI NIH HHSUnited StatesK23CA149079PubMed and NIHNIH RePORTER
K12CA157688NIHNIH RePORTER

Download CSV of grants

References283

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123856031Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models.Cancer Lett2013https://conductscience.org/library/papers/23856031PubMed
219692680Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.N Engl J Med2009https://conductscience.org/library/papers/19692680PubMed
321941284A decade of exploring the cancer epigenome - biological and translational implications.Nat Rev Cancer2011https://conductscience.org/library/papers/21941284PubMed
41679529Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines.Oncogene1991https://conductscience.org/library/papers/1679529PubMed
523922022
Volumetric tumor growth in advanced non-small cell lung cancer patients with EGFR mutations during EGFR-tyrosine kinase inhibitor therapy: developing criteria to continue therapy beyond RECIST progression.
Cancer2013https://conductscience.org/library/papers/23922022PubMed
623806793Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer.Lung Cancer2013https://conductscience.org/library/papers/23806793PubMed
723770567Mutational heterogeneity in cancer and the search for new cancer-associated genes.Nature2013https://conductscience.org/library/papers/23770567PubMed
824302556Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancer.Cancer Discov2014https://conductscience.org/library/papers/24302556PubMed
922761469Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas.Clin Cancer Res2012https://conductscience.org/library/papers/22761469PubMed
1023546521The future of epigenetic therapy in solid tumours--lessons from the past.Nat Rev Clin Oncol2013https://conductscience.org/library/papers/23546521PubMed
1117047648A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations.Br J Cancer2006https://conductscience.org/library/papers/17047648PubMed
1222837387Transforming fusions of FGFR and TACC genes in human glioblastoma.Science2012https://conductscience.org/library/papers/22837387PubMed
1322776234The genetics and biology of KRAS in lung cancer.Chin J Cancer2013https://conductscience.org/library/papers/22776234PubMed
1421711248Fibroblast growth factors and their receptors in cancer.Biochem J2011https://conductscience.org/library/papers/21711248PubMed
1515735036Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer.Cancer Res2005https://conductscience.org/library/papers/15735036PubMed
1622975805The transcriptional landscape and mutational profile of lung adenocarcinoma.Genome Res2012https://conductscience.org/library/papers/22975805PubMed
1722327623RET, ROS1 and ALK fusions in lung cancer.Nat Med2012https://conductscience.org/library/papers/22327623PubMed
1823887156ROS1 immunohistochemistry for detection of ROS1-rearranged lung adenocarcinomas.Am J Surg Pathol2013https://conductscience.org/library/papers/23887156PubMed
1920826737Improved endpoints for cancer immunotherapy trials.J Natl Cancer Inst2010https://conductscience.org/library/papers/20826737PubMed
2023533264Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas.Cancer Discov2013https://conductscience.org/library/papers/23533264PubMed

See all 283 referencesDownload CSV of references

Cited by68

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 112 citations.

PMIDTitleJournalYearIn PapersSource
41021160Mechanistic evaluation of hyperoside against non-small cell lung cancer: a combined approach of network pharmacology and in vitro experimental validation.Discov Oncol2025https://conductscience.org/library/papers/41021160PubMed
40965349EGFR Mutation Detection in Whole Slide Images of Non-Small Cell Lung Cancers Using a Two-Stage Deep Transfer Learning Approach.Cancer Med2025https://conductscience.org/library/papers/40965349PubMed
40916818Radiogenomics-based prediction of KRAS and EGFR gene mutation in non-small cell lung cancer patients.Zhong Nan Da Xue Xue Bao Yi Xue Ban2025https://conductscience.org/library/papers/40916818PubMed
40805126Orthotopically Implanted Murine Lung Adenocarcinoma Cell Lines for Preclinical Investigations.Cancers (Basel)2025https://conductscience.org/library/papers/40805126PubMed
40568577Multi-omics analysis untangles the crosstalk between intratumor microbiome, lactic acid metabolism and immune status in lung squamous cell carcinoma.Front Immunol2025https://conductscience.org/library/papers/40568577PubMed
40292291Plasma IgG and IgM autoantibodies to COPT1 as potential biomarkers for detection of non-small cell lung cancer.Front Immunol2025https://conductscience.org/library/papers/40292291PubMed
39754146Aidi injection inhibits the migration and invasion of gefitinib-resistant lung adenocarcinoma cells by regulating the PLAT/FAK/AKT pathway.Chin Med2025https://conductscience.org/library/papers/39754146PubMed
39679460Emerging AXL Inhibitors in Oncology: Chemical and Biological Advances in Targeted Cancer Therapy.Anticancer Agents Med Chem2025https://conductscience.org/library/papers/39679460PubMed
38989152Assessing the benefits and safety profile of incorporating poly ADP-ribose polymerase (PARP) inhibitors in the treatment of advanced lung cancer: a thorough systematic review and meta-analysis.Front Pharmacol2024https://conductscience.org/library/papers/38989152PubMed
38707278Dacomitinib exhibits promising activity against the rare HER2 exon 20 insertion M774delinsWLV in lung cancer: A case report and literature review.Heliyon2024https://conductscience.org/library/papers/38707278PubMed
38398169Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy.Cancers (Basel)2024https://conductscience.org/library/papers/38398169PubMed
36031613Pyrotinib combined with apatinib for targeting metastatic non-small cell lung cancer with HER2 alterations: a prospective, open-label, single-arm phase 2 study (PATHER2).BMC Med2022https://conductscience.org/library/papers/36031613PubMed
35946957βIII-tubulin suppression enhances the activity of Amuvatinib to inhibit cell proliferation in c-Met positive non-small cell lung cancer cells.Cancer Med2023https://conductscience.org/library/papers/35946957PubMed
35799269Identification of a cytokine-dominated immunosuppressive class in squamous cell lung carcinoma with implications for immunotherapy resistance.Genome Med2022https://conductscience.org/library/papers/35799269PubMed
35284122Mutational characteristics of young and elderly gastric cancer: a comparative study.J Gastrointest Oncol2022https://conductscience.org/library/papers/35284122PubMed
35117179Functional analysis of long-chain non-coding RNA in oral squamous cell carcinoma.Transl Cancer Res2020https://conductscience.org/library/papers/35117179PubMed
34820522A proposal for score assignment to characterize biological processes from mass spectral analysis of serum.Clin Mass Spectrom2020https://conductscience.org/library/papers/34820522PubMed
34711122MiR-133b suppresses the proliferation, migration and invasion of lung adenocarcinoma cells by targeting SKA3.Cancer Biol Ther2021https://conductscience.org/library/papers/34711122PubMed
34599863Driver gene alterations profiling of Chinese non-small cell lung cancer and the effects of co-occurring alterations on immunotherapy.Cancer Med2021https://conductscience.org/library/papers/34599863PubMed
34572523Shifting Gears in Precision Oncology-Challenges and Opportunities of Integrative Data Analysis.Biomolecules2021https://conductscience.org/library/papers/34572523PubMed

See all 68 cited byDownload CSV of cited by

Genes142

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABL125PubTator's text mininghttps://conductscience.org/library/genes/25NCBI Gene
AGT183PubTator's text mininghttps://conductscience.org/library/genes/183NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
AURKA6790PubTator's text mininghttps://conductscience.org/library/genes/6790NCBI Gene
AURKB9212PubTator's text mininghttps://conductscience.org/library/genes/9212NCBI Gene
AXL558PubTator's text mininghttps://conductscience.org/library/genes/558NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BCR613PubTator's text mininghttps://conductscience.org/library/genes/613NCBI Gene
BDNF627PubTator's text mininghttps://conductscience.org/library/genes/627NCBI Gene
BIRC2329PubTator's text mininghttps://conductscience.org/library/genes/329NCBI Gene
BIRC779444PubTator's text mininghttps://conductscience.org/library/genes/79444NCBI Gene
BMI1648PubTator's text mininghttps://conductscience.org/library/genes/648NCBI Gene
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
CBL867PubTator's text mininghttps://conductscience.org/library/genes/867NCBI Gene
CBLL2158506PubTator's text mininghttps://conductscience.org/library/genes/158506NCBI Gene
CCDC68030PubTator's text mininghttps://conductscience.org/library/genes/8030NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD58965PubTator's text mininghttps://conductscience.org/library/genes/965NCBI Gene

See all 142 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25535693

GET https://conductscience.org/api/papers/v1/25535693/authors?page=2